Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Sand (Herlev, Denmark), S. Rønnow (Herlev, Denmark), L. Langholm (Herlev, Denmark), M. Karsdal (Herlev, Denmark), T. Manon-Jensen (Herlev, Denmark), R. Tal-Singer (Collegeville, PA, United States of America), B. Miller (Collegeville, PA, United States of America), J. Vestbo (Manchester, United Kingdom), D. Leeming (Herlev, Denmark). A combination of biomarkers for fibrinolysis and basement membrane destruction predicts mortality in the ECLIPSE COPD cohort. 4716

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Biomarkers of extracellular matrix turnover predict mortality in the ECLIPSE COPD cohort Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort Source: Eur Respir J, 57 (3) 2001339; 10.1183/13993003.01339-2020 Year: 2021 Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients Source: ERJ Open Res, 5 (2) 00021-2019; 10.1183/23120541.00021-2019 Year: 2019 Investigating effects of nintedanib on biomarkers of ECM turnover in patients with IPF: the INMARK study Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018 Vascular and basement membrane remodelling in smokers and COPD Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009 Effects of anti-inflammatory treatment on concentration of cytokines and thickness of basement membrane in patients with moderate COPD – preliminary results Source: Eur Respir J 2007; 30: Suppl. 51, 140s Year: 2007 Basement membrane remodeling is related to disease progression and severity in idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 Blood biomarkers in COPD: results from the ECLIPSE (evaluation of COPD longitudinally to identify predictive surrogate endpoints) cohort Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD Year: 2009 The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation Year: 2013 1-year prospective study in severe COPD patients: marker of inflammation, lung function and radiologic evaluation Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD Source: Eur Respir J 2016; 47:1365-1373 Year: 2016 LATE-BREAKING ABSTRACT: Biomarkers of tissue turnover are related to annual change in FEV1 in patients with COPD within the ECLIPSE cohort Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Estimation of a disease progression model for COPD using data from the ECLIPSE study Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013 Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 The impact of vaccination on the dynamics of bronchial and systemic inflammation in patients with COPD and CHD Source: International Congress 2017 – COPD management Year: 2017 Identifying systemic inflammatory markers in the Melbourne COPD exacerbation cohort Source: Eur Respir J 2005; 26: Suppl. 49, 51s Year: 2005 External validation of two prognostic scores predicting exacerbations in ECLIPSE COPD patients Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities Year: 2020 Identification of distinct trajectories of FEV1 progression in the ECLIPSE cohort Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine Year: 2021 Associations between arterial calcification and stiffness, bone density, emphysema and all-cause mortality in COPD patients Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 The composite physiological index strongly predicts mortality in interstitial lung disease (ILD) associated pulmonary hypertension (PH-ILD) Source: International Congress 2017 – Imaging and lung disease PH Year: 2017